Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 10 | 2022 | 6011 | 1.360 |
Why?
|
| Adrenal Cortex Hormones | 6 | 2022 | 1855 | 1.070 |
Why?
|
| Contact Tracing | 2 | 2016 | 273 | 0.820 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2019 | 55 | 0.700 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2016 | 624 | 0.640 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 536 | 0.600 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 274 | 0.580 |
Why?
|
| Administration, Inhalation | 5 | 2022 | 1105 | 0.520 |
Why?
|
| Th2 Cells | 1 | 2020 | 1061 | 0.520 |
Why?
|
| DNA Methylation | 2 | 2019 | 4286 | 0.510 |
Why?
|
| Food Hypersensitivity | 1 | 2022 | 622 | 0.500 |
Why?
|
| Organoplatinum Compounds | 1 | 2015 | 408 | 0.470 |
Why?
|
| Eosinophils | 1 | 2018 | 955 | 0.470 |
Why?
|
| Neuropeptides | 1 | 2019 | 942 | 0.460 |
Why?
|
| Drug Resistance | 1 | 2019 | 1609 | 0.440 |
Why?
|
| Carboplatin | 1 | 2015 | 801 | 0.420 |
Why?
|
| Sexual Partners | 1 | 2016 | 730 | 0.410 |
Why?
|
| Drug Hypersensitivity | 2 | 2020 | 884 | 0.390 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.370 |
Why?
|
| Homosexuality, Male | 1 | 2016 | 1240 | 0.320 |
Why?
|
| Circumcision, Male | 1 | 2009 | 150 | 0.310 |
Why?
|
| Mass Media | 1 | 2009 | 305 | 0.280 |
Why?
|
| IgG Deficiency | 1 | 2020 | 28 | 0.190 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 93 | 0.180 |
Why?
|
| China | 2 | 2016 | 2248 | 0.160 |
Why?
|
| Placebo Effect | 1 | 2020 | 502 | 0.140 |
Why?
|
| CpG Islands | 1 | 2019 | 1172 | 0.130 |
Why?
|
| Desensitization, Immunologic | 2 | 2020 | 483 | 0.130 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1588 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 736 | 0.120 |
Why?
|
| False Negative Reactions | 1 | 2015 | 588 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 1616 | 0.120 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 1743 | 0.120 |
Why?
|
| Skin Tests | 1 | 2015 | 613 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2107 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Treponema pallidum | 1 | 2011 | 40 | 0.100 |
Why?
|
| Child | 5 | 2020 | 77709 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1889 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2011 | 106 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 1400 | 0.100 |
Why?
|
| Humans | 18 | 2022 | 744343 | 0.090 |
Why?
|
| Male | 10 | 2020 | 350118 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 1213 | 0.090 |
Why?
|
| Syphilis | 1 | 2011 | 227 | 0.080 |
Why?
|
| Vaginal Smears | 1 | 2012 | 511 | 0.080 |
Why?
|
| Prognosis | 2 | 2020 | 29063 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2012 | 590 | 0.080 |
Why?
|
| Adult | 7 | 2020 | 214055 | 0.070 |
Why?
|
| Africa South of the Sahara | 1 | 2009 | 724 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12026 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12261 | 0.070 |
Why?
|
| Female | 8 | 2020 | 380194 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 2012 | 1119 | 0.070 |
Why?
|
| Bibliometrics | 1 | 2009 | 339 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7322 | 0.070 |
Why?
|
| Young Adult | 4 | 2020 | 56430 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3752 | 0.060 |
Why?
|
| Lung | 2 | 2021 | 9856 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6103 | 0.060 |
Why?
|
| Adolescent | 3 | 2020 | 85781 | 0.060 |
Why?
|
| Risk | 1 | 2015 | 9687 | 0.060 |
Why?
|
| HIV Infections | 1 | 2009 | 16718 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15076 | 0.050 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13284 | 0.050 |
Why?
|
| Genotype | 2 | 2012 | 12951 | 0.050 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 1587 | 0.050 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2021 | 302 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 275 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 572 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 551 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 652 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 687 | 0.030 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2012 | 40 | 0.030 |
Why?
|
| Phylogeography | 1 | 2011 | 82 | 0.030 |
Why?
|
| Women, Working | 1 | 2012 | 87 | 0.020 |
Why?
|
| United States | 1 | 2018 | 69872 | 0.020 |
Why?
|
| Asia | 1 | 2012 | 610 | 0.020 |
Why?
|
| Aged | 1 | 2022 | 163280 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 468 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4560 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 2987 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 77449 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7799 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2902 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 213383 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 18370 | 0.010 |
Why?
|
| Women's Health | 1 | 2012 | 2034 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15519 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15226 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 72290 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_